Signal Transduction by Oxysterols
氧甾醇的信号转导
基本信息
- 批准号:8694262
- 负责人:
- 金额:$ 41.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-05 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdherenceAdministrative PersonnelAffinity LabelsAgonistAlanineAmino AcidsArbitrationAtherosclerosisAuthorshipBindingBinding SitesBiochemicalBiologicalBiological AssayBiologyBiotinBoxingBudgetsCell CommunicationCell ExtractsCell physiologyCellsCellular biologyChemicalsChemistryCholesterolClinicCollaborationsCommittee MembersCommunicationConflict (Psychology)Congenital AbnormalityCoupledDataData AnalysesDevelopmentDigestionDiseaseDrug TargetingElectronic MailEnsureErinaceidaeEthicsExperimental DesignsFunctional disorderFundingGenerationsGoalsGrantHumanHuman ResourcesHydroxycholesterolsImageInborn Errors of MetabolismInflammationInstitutionIntegral Membrane ProteinIntellectual PropertyLaboratoriesLeadershipLegal patentLigandsLipidsLocationMalignant NeoplasmsMapsMass Spectrum AnalysisMediatingMetabolic DiseasesMethodsMolecularMutagenesisNatural regenerationNatureNerve DegenerationOncogene ProteinsOrganic ChemistryOrganic SynthesisOutcomePaperPatch TestsPathway interactionsPeptidesPharmaceutical PreparationsPhasePhotoaffinity LabelsPlayPortraitsPreparationProcessProgress ReportsProtein BiochemistryProteinsPublicationsPublished CommentPublishingReceptor SignalingRecruitment ActivityRegulationRelative (related person)ResearchResearch PersonnelResearch Project GrantsResistanceResolutionResourcesRoleSafetySamplingScanningSecond Messenger SystemsSignal PathwaySignal TransductionSignaling MoleculeSiteSteroidsSterolsStreptavidinStructureSuggestionSynthesis ChemistrySystemTechniquesTechnology TransferTelephoneTestingTherapeuticTimeTimeLineUnited States National Institutes of HealthUniversitiesWashingtonWorkaffinity labelinganalogbaseconflict resolutioncyclopaminedata sharingdesignexperiencegene replacementhedgehog signal transductionhuman SMO proteinimmune functioninhibitor/antagonistinterdisciplinary collaborationlipid metabolismmeetingsmutantnoveloncologyorganizational structureoxidationprogramsreceptorresearch studyresponsescaffoldsecond messengersmall moleculesmoothened signaling pathwaysymposiumtool
项目摘要
DESCRIPTION (provided by applicant): Oxysterols are a class of endogenous cellular lipids derived from cholesterol that have been implicated in the pathophysiology of atherosclerosis, inborn errors of metabolism, inflammation and cancer. In many cases, the proteins and molecular pathways through which these enigmatic molecules exert their powerful biological effects remain unknown. We established collaboration between a synthetic organic chemist and a cell biologist to understand how oxysterols activate the Hedgehog (Hh) signaling system, a pathway that plays important roles in development, regeneration and cancer. We discovered that a specific oxysterol, 20(S)-OHC, is an allosteric activator of the 7-pass transmembrane protein Smoothened (Smo), a human oncoprotein and key drug target in oncology. This finding significantly expands the regulatory scope of oxysterols as signaling molecules, demonstrating their capacity to function as direct agonists for both a human on co-protein and a signaling receptor. Based on preliminary work, we hypothesize that endogenous 20(S)-OHC functions as a second-messenger in Hh signaling. Using a combination of mutagenesis, photo affinity labeling, and mass spectrometry, we will map the region of Smo that interacts with 20(S)-OHC to provide a biochemical portrait of this novel class of receptor-ligand interaction (Aim 1). Using
quantitative mass spectrometry and a click chemistry-based imaging assay, we will ask if Hedgehog signaling can alter cellular levels or distribution of 20(S)-OHC (Aim 2). Finally, we will
develop and characterize novel Hh pathway inhibitors that are inspired by oxysterol scaffolds (Aim 3). We expect three major outcomes to emerge from the successful completion of this project: (1) An answer to the question of how Smo is regulated in cells, perhaps the longest-standing mystery in the Hh pathway, (2) a biochemical understanding of how oxysterols engage and regulate 7-pass signaling receptors, and (3) the development of an integrative toolkit that can be deployed to dissect any other oxysterol- regulated cellular process. To accomplish these goals, we have recruited a team of investigators with complementary expertise in cell biology, protein biochemistry, synthetic chemistry, and mass spectrometry.
描述(由申请人提供):氧固醇是一类来源于胆固醇的内源性细胞脂质,与动脉粥样硬化、先天性代谢缺陷、炎症和癌症的病理生理学有关。在许多情况下,这些神秘分子发挥其强大生物效应的蛋白质和分子途径仍然未知。我们在合成有机化学家和细胞生物学家之间建立了合作,以了解氧固醇如何激活Hedgehog(Hh)信号系统,这是一种在发育,再生和癌症中发挥重要作用的途径。我们发现,一种特定的氧固醇,20(S)-OHC,是一种变构激活剂的7-通过跨膜蛋白Smoothened(Smo),人类癌蛋白和关键药物靶点在肿瘤学。这一发现显着扩大了氧固醇作为信号分子的调节范围,证明它们有能力作为人类辅助蛋白和信号受体的直接激动剂。基于前期工作,我们假设内源性20(S)-OHC在Hh信号转导中作为第二信使发挥作用。使用诱变,光亲和标记和质谱的组合,我们将映射与20(S)-OHC相互作用的Smo区域,以提供这类新型受体-配体相互作用的生化特征(目的1)。使用
通过定量质谱和基于点击化学的成像测定,我们将询问Hedgehog信号传导是否可以改变20(S)-OHC(Aim 2)的细胞水平或分布。最后我们将
开发和表征受氧固醇支架启发的新型Hh途径抑制剂(目标3)。我们预计,成功完成这一项目将产生三大成果:(1)Smo在细胞中如何调节的问题的答案,也许是Hh通路中存在时间最长的谜团,(2)对氧固醇如何参与和调节7-pass信号受体的生物化学理解,以及(3)开发一个综合工具包,该工具包可以用于剖析任何其他氧固醇调节的细胞过程。为了实现这些目标,我们招募了一组在细胞生物学,蛋白质生物化学,合成化学和质谱方面具有互补专业知识的研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLAS F COVEY其他文献
DOUGLAS F COVEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLAS F COVEY', 18)}}的其他基金
Development of chemical biology tools for NMDA receptors
NMDA 受体化学生物学工具的开发
- 批准号:
9310158 - 财政年份:2017
- 资助金额:
$ 41.8万 - 项目类别:
STRUCTURE/ACTIVITY STUDIES OF NEUROSTEROID ANALOGUES
神经类固醇类似物的结构/活性研究
- 批准号:
8118826 - 财政年份:2010
- 资助金额:
$ 41.8万 - 项目类别:
STRUCTURE/ACTIVITY STUDIES OF NEUROSTEROID ANALOGUES
神经类固醇类似物的结构/活性研究
- 批准号:
7384096 - 财政年份:2007
- 资助金额:
$ 41.8万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 41.8万 - 项目类别:
Fellowship Programs